Central ND News

Congresswoman Julie Fedorchak has announced the House's approval of the HALT Fentanyl Act, which aims to classify fentanyl-related substances as Schedule I drugs under the Controlled Substances Act. The bill, H.R. 27, received a bipartisan vote of 312-108 and was co-sponsored by Fedorchak.

"North Dakota law enforcement say record amounts of fentanyl are pouring into our state. What's most disturbing is how traffickers are targeting our kids. They're poisoning our children and leaving families shattered," Fedorchak stated.

During discussions on the House Floor, Fedorchak emphasized that the legislation provides law enforcement with necessary authority to seize these substances and pursue legal action against traffickers.

Fentanyl and its analogues have been identified as significantly stronger than heroin and morphine, with even small quantities being potentially lethal. These substances have become a leading cause of death for Americans under 50 years old.

"With more than 200 Americans dying every day from fentanyl or opioid-related poisonings, the stakes are high. By passing the HALT Fentanyl Act with an overwhelming bipartisan vote, Congress is sending a clear message: Law enforcement will have the tools they need to combat this danger, and traffickers who push these poisons into our communities will face justice," concluded Fedorchak.

In North Dakota, overdose deaths involving fentanyl have increased since 2019. Currently, an average of two residents die weekly from drug overdoses in which fentanyl is often present.

The HALT Fentanyl Act aims to close legal loopholes exploited by traffickers while providing resources for law enforcement to address trafficking issues effectively. It also promotes scientific research to understand better and manage fentanyl-related substances.